Upstream Bio (UPB) Appoints Stacy Price as Chief Technology Officer

Go back to Upstream Bio (UPB) Appoints Stacy Price as Chief Technology Officer

Upstream Bio Appoints Stacy Price as Chief Technology Officer

May 20, 2025 7:00 AM UTC

WALTHAM, Mass., May 20, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced the appointment of Stacy Price, MS, PMP, as Chief Technology Officer. Ms. Price brings over 25 years of experience in technical operations, manufacturing, and product development in the biotechnology industry, across a... More